Sinopharm Group: Terminate the issuance of A shares to specific targets through simplified procedures in 2024.

The Shen Nong Group announced that the company held the third meeting of the fifth board of directors on July 28, 2025, and approved the proposal of "Terminating the issuance of A shares to specific objects through a simplified procedure in 2024 and withdrawing the application documents". The company has decided to terminate the issuance of A shares to specific objects through a simplified procedure in 2024 and withdraw the application documents. This decision was made based on changes in the market environment, taking into consideration factors such as the capital market conditions and the overall development plan of the company.